Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancer.

Navidi M, Phillips AW, Griffin SM, Duffield KE, Greystoke A, Sumpter K, Sinclair RCF.

Br J Surg. 2018 Jun;105(7):900-906. doi: 10.1002/bjs.10802. Epub 2018 Mar 30.

PMID:
29601082
2.

A phase I study of anti-inflammatory therapy with rilonacept in adolescents and adults with type 1 diabetes mellitus.

White PC, Adhikari S, Grishman EK, Sumpter KM.

Pediatr Diabetes. 2018 Jun;19(4):788-793. doi: 10.1111/pedi.12634. Epub 2018 Mar 4.

PMID:
29504185
3.

A novel paraneoplastic syndrome with acquired lipodystrophy and chronic inflammatory demyelinating polyneuropathy in an adolescent male with craniopharyngioma.

Lockemer HE, Sumpter KM, Cope-Yokoyama S, Garg A.

J Pediatr Endocrinol Metab. 2018 Mar 28;31(4):479-483. doi: 10.1515/jpem-2017-0222.

PMID:
29455190
4.

End of life planning for 'hard to reach' communities.

Sumpter K.

Nurs Older People. 2017 Jun 30;29(6):14. doi: 10.7748/nop.29.6.14.s15.

PMID:
28664792
5.

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.

Cunningham D, Stenning SP, Smyth EC, Okines AF, Allum WH, Rowley S, Stevenson L, Grabsch HI, Alderson D, Crosby T, Griffin SM, Mansoor W, Coxon FY, Falk SJ, Darby S, Sumpter KA, Blazeby JM, Langley RE.

Lancet Oncol. 2017 Mar;18(3):357-370. doi: 10.1016/S1470-2045(17)30043-8. Epub 2017 Feb 3.

6.

Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK Audit.

King J, Palmer DH, Johnson P, Ross P, Hubner RA, Sumpter K, Darby S, Braconi C, Iwuji C, Swinson D, Collins P, Patel K, Nobes J, Muazzam I, Blesing C, Kirkwood A, Nash S, Meyer T.

Clin Oncol (R Coll Radiol). 2017 Apr;29(4):256-262. doi: 10.1016/j.clon.2016.11.012. Epub 2016 Dec 10.

PMID:
27964898
7.

Prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomy.

Lagarde SM, Navidi M, Gisbertz SS, van Laarhoven HW, Sumpter K, Meijer SL, Disep B, Immanuel A, Griffin SM, van Berge Henegouwen MI.

Br J Surg. 2016 Nov;103(12):1658-1664. doi: 10.1002/bjs.10226. Epub 2016 Oct 3.

PMID:
27696382
8.

A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma.

Edeline J, Blanc JF, Johnson P, Campillo-Gimenez B, Ross P, Ma YT, King J, Hubner RA, Sumpter K, Darby S, Evans J, Iwuji C, Swinson D, Collins P, Patel K, Muazzam I, Palmer DH, Meyer T.

Liver Int. 2016 Dec;36(12):1821-1828. doi: 10.1111/liv.13170. Epub 2016 Jun 22.

PMID:
27214151
9.

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial.

Pearson A, Smyth E, Babina IS, Herrera-Abreu MT, Tarazona N, Peckitt C, Kilgour E, Smith NR, Geh C, Rooney C, Cutts R, Campbell J, Ning J, Fenwick K, Swain A, Brown G, Chua S, Thomas A, Johnston SRD, Ajaz M, Sumpter K, Gillbanks A, Watkins D, Chau I, Popat S, Cunningham D, Turner NC.

Cancer Discov. 2016 Aug;6(8):838-851. doi: 10.1158/2159-8290.CD-15-1246. Epub 2016 May 13.

10.

The impact of neoadjuvant chemotherapy on cardiopulmonary physical fitness in gastro-oesophageal adenocarcinoma.

Sinclair R, Navidi M, Griffin SM, Sumpter K.

Ann R Coll Surg Engl. 2016 Jul;98(6):396-400. doi: 10.1308/rcsann.2016.0135. Epub 2016 May 3.

11.

Fitness after chemotherapy.

Sinclair RC, Sumpter K, Griffin SM.

Br J Anaesth. 2016 Jan;116(1):140. doi: 10.1093/bja/aev419. No abstract available.

12.

60 seconds with Karen Sumpter.

Sumpter K.

Nurs Times. 2015 Apr 1-7;111(14):24. No abstract available.

PMID:
26182588
13.

3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.

Challapalli A, Barwick T, Pearson RA, Merchant S, Mauri F, Howell EC, Sumpter K, Maxwell RJ, Aboagye EO, Sharma R.

Eur J Nucl Med Mol Imaging. 2015 May;42(6):831-40. doi: 10.1007/s00259-015-3000-2. Epub 2015 Feb 12.

PMID:
25673055
14.

Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.

Valle JW, Palmer D, Jackson R, Cox T, Neoptolemos JP, Ghaneh P, Rawcliffe CL, Bassi C, Stocken DD, Cunningham D, O'Reilly D, Goldstein D, Robinson BA, Karapetis C, Scarfe A, Lacaine F, Sand J, Izbicki JR, Mayerle J, Dervenis C, Oláh A, Butturini G, Lind PA, Middleton MR, Anthoney A, Sumpter K, Carter R, Büchler MW.

J Clin Oncol. 2014 Feb 20;32(6):504-12. doi: 10.1200/JCO.2013.50.7657. Epub 2014 Jan 13.

PMID:
24419109
15.

Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team.

Dyson J, Jaques B, Chattopadyhay D, Lochan R, Graham J, Das D, Aslam T, Patanwala I, Gaggar S, Cole M, Sumpter K, Stewart S, Rose J, Hudson M, Manas D, Reeves HL.

J Hepatol. 2014 Jan;60(1):110-7. doi: 10.1016/j.jhep.2013.08.011. Epub 2013 Aug 23.

PMID:
23978719
16.

Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes.

Sumpter KM, Adhikari S, Grishman EK, White PC.

Pediatr Diabetes. 2011 Nov;12(7):656-67. doi: 10.1111/j.1399-5448.2011.00761.x. Epub 2011 Apr 24.

PMID:
21518168
17.

Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study.

Rao S, Starling N, Cunningham D, Sumpter K, Gilligan D, Ruhstaller T, Valladares-Ayerbes M, Wilke H, Archer C, Kurek R, Beadman C, Oates J.

Ann Oncol. 2010 Nov;21(11):2213-9. doi: 10.1093/annonc/mdq247. Epub 2010 May 23.

PMID:
20497967
18.

Experimental and numerical study of spread and sorption of VX sessile droplets into medium grain-size sand.

D'Onofrio TG, Navaz HK, Markicevic B, Mantooth BA, Sumpter KB.

Langmuir. 2010 Mar 2;26(5):3317-22. doi: 10.1021/la903071q.

PMID:
19947625
19.

Kinetics of the degradation of sulfur mustard on ambient and moist concrete.

Brevett CA, Sumpter KB, Nickol RG.

J Hazard Mater. 2009 Feb 15;162(1):281-91. doi: 10.1016/j.jhazmat.2008.05.033. Epub 2008 May 15.

PMID:
18584953
20.

Degradation of the blister agent sulfur mustard, bis(2-chloroethyl) sulfide, on concrete.

Brevett CA, Sumpter KB, Wagner GW, Rice JS.

J Hazard Mater. 2007 Feb 9;140(1-2):353-60. Epub 2006 Sep 28.

PMID:
17049727
21.

Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF.

Sumpter K, Harper-Wynne C, Cunningham D, Rao S, Tebbutt N, Norman AR, Ward C, Iveson T, Nicolson M, Hickish T, Hill M, Oates J.

Br J Cancer. 2005 Jun 6;92(11):1976-83.

22.

Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control.

Harper-Wynne CL, Sumpter K, Ryan C, Priest K, Norton A, Ross P, Ford HE, Johnson P, O'Brien ME.

Lung Cancer. 2005 Feb;47(2):289-90. No abstract available.

PMID:
15639729
23.

Is the second line data on the use of docetaxel in non-small cell lung cancer reproducible?

Sumpter K, Harper-Wynne C, Yeoh C, Popat S, Ashley S, Norton A, O'Brien M.

Lung Cancer. 2004 Mar;43(3):369-70. No abstract available.

PMID:
15165099
24.

Severe acute interstitial pnuemonia and gefitinib.

Sumpter K, Harper-Wynne C, O'Brien M, Congleton J.

Lung Cancer. 2004 Mar;43(3):367-8. No abstract available.

PMID:
15165098
25.

Phase III study of mitomycin-C with protracted venous infusion or circadian-timed infusion of 5-fluorouracil in advanced colorectal carcinoma.

Price TJ, Ross PJ, Hickish T, Tait D, Norman AR, Ford HE, Middleton G, Sumpter K, Hill M, Oates J, Cunningham D.

Clin Colorectal Cancer. 2004 Feb;3(4):235-42.

PMID:
15025796
26.

Oxaliplatin and capecitabine chemotherapy for advanced colorectal cancer: a single institution's experience.

Sumpter K, Harper-Wynne C, Cunningham D, Gillbanks A, Norman AR, Hill M.

Clin Oncol (R Coll Radiol). 2003 Aug;15(5):221-6.

PMID:
12924449
27.

Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer.

Chau I, Allen M, Cunningham D, Tait D, Brown G, Hill M, Sumpter K, Rhodes A, Wotherspoon A, Norman AR, Hill A, Massey A, Prior Y.

Br J Cancer. 2003 Apr 7;88(7):1017-24.

28.

Combination chemotherapy and colorectal cancer.

Sumpter K, Cunningham D.

Semin Oncol. 2000 Oct;27(5 Suppl 10):105-11. Review. No abstract available.

PMID:
11049041
29.

Oral idarubicin as a single agent therapy in patients with relapsed or resistant multiple myeloma.

Sumpter K, Powles RL, Raje N, Ramiah V, Kulkarni S, Treleaven J, Mainwaring PN.

Leuk Lymphoma. 1999 Nov;35(5-6):593-7.

PMID:
10609797

Supplemental Content

Loading ...
Support Center